Egis is present in 61 countries with its products.
Our portfolio contains 634 products. Our highlighted therapeutical areas are the cardiovascular system, the central nervous system and the respiratory system.Learn more
Egis is present in 61 countries with its products.Click here to learn more
Our activities incorporate all areas in the pharmaceutical value chainClick here to learn more
One of the fundamental pillars of our strategy is innovation. We devoted about EUR 45 million to research and development in the 2020/2021 financial year.Click here to learn more
Please report any adverse events possibly related to the products of Egis Pharmaceuticals PLC, to any of the listed contacts below.